Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 2 of 2
Full-Text Articles in Medicine and Health Sciences
Acr Appropriateness Criteria® On Cerebrovascular Disease, Robert L. Delapaz, Franz J. Wippold Ii, Rebecca S. Cornelius, Sepideh Amin-Hanjani, Edgardo J. Angtuaco, Daniel F. Broderick, Douglas C. Brown, Jeffrey L. Creasy, Patricia C. Davis, Charles F. Garvin, Brian L. Hoh, Charles T. Mcconnell Jr, Laszlo L. Mechtler, David J. Seidenwurm, James G. Smirniotopoulos, Paul J. Tobben, Alan D. Waxman, Greg J. Zipfel
Acr Appropriateness Criteria® On Cerebrovascular Disease, Robert L. Delapaz, Franz J. Wippold Ii, Rebecca S. Cornelius, Sepideh Amin-Hanjani, Edgardo J. Angtuaco, Daniel F. Broderick, Douglas C. Brown, Jeffrey L. Creasy, Patricia C. Davis, Charles F. Garvin, Brian L. Hoh, Charles T. Mcconnell Jr, Laszlo L. Mechtler, David J. Seidenwurm, James G. Smirniotopoulos, Paul J. Tobben, Alan D. Waxman, Greg J. Zipfel
Uniformed Services University of the Health Sciences
Stroke is the sudden onset of focal neurologic symptoms due to ischemia or hemorrhage in the brain. Current FDA-approved clinical treatment of acute ischemic stroke involves the use of the intravenous thrombolytic agent recombinant tissue plasminogen activator given >3 hours after symptom onset, following the exclusion of intracerebral hemorrhage by a noncontrast CT scan. Advanced MRI, CT, and other techniques may confirm the stroke diagnosis and subtype, demonstrate lesion location, identify vascular occlusion, and guide other management decisions but, within the first 3 hours after ictus, should not delay or be used to withhold recombinant tissue plasminogen activator therapy after …
Comparison Of Combat Gauze And Traumastat In Two Severe Groin Injury Models, Françoise Arnaud, Kohsuke Teranishi, Tomoaki Okada, Dione Parreño-Sacdalan, Daniel Hupalo, George Mcnamee, Walter Carr, David Burris, Richard Mccarron
Comparison Of Combat Gauze And Traumastat In Two Severe Groin Injury Models, Françoise Arnaud, Kohsuke Teranishi, Tomoaki Okada, Dione Parreño-Sacdalan, Daniel Hupalo, George Mcnamee, Walter Carr, David Burris, Richard Mccarron
Uniformed Services University of the Health Sciences
Background. Fabric-like hemostatic dressings offer promise for hemorrhage control in noncompressible areas, especially given their similarity in form to standard gauze currently in use. Recently, two such products, Combat Gauze (CBG) and TraumaStat (TMS), were introduced. Their performance is evaluated in two vascular injury models.
Materials andMethods. The dressings were evaluated in anesthetized Yorkshire pigs, hemorrhaged by full transection of the femoral vasculature with 2 min free bleeding period (CBG = 6, TMS = 6) or by 4 mm femoral arterial puncture with 45 s free bleeding period (CBG = 8, TMS = 8). After injury, dressings were applied, followed …